172 related articles for article (PubMed ID: 31594398)
1. An epidemiological profile of dysarthria incidence and assistive technology use in the living population of people with MND in Scotland.
Elliott E; Newton J; Rewaj P; Gregory JM; Tomarelli L; Colville S; Chandran S; Pal S;
Amyotroph Lateral Scler Frontotemporal Degener; 2020 Feb; 21(1-2):116-122. PubMed ID: 31594398
[No Abstract] [Full Text] [Related]
2. A pilot study of AID-COMp: An innovative speech-language intervention for patients with early-stage major neurocognitive disorder.
Chesneau S; Mekary M; Chayer N; Le Dorze G
Int J Lang Commun Disord; 2022 May; 57(3):524-538. PubMed ID: 35098609
[TBL] [Abstract][Full Text] [Related]
3. National audit of cognitive assessment in people with pwMND A national audit of cognitive assessment in people with motor neurone disease (pwMND) in Scotland.
Stavrou M; Newton J; Stott G; Colville S; Chandran S; Abrahams S; Pal S; Davenport R
Amyotroph Lateral Scler Frontotemporal Degener; 2020 Aug; 21(5-6):459-462. PubMed ID: 32308027
[TBL] [Abstract][Full Text] [Related]
4. The Prevalence and Management of Saliva Problems in Motor Neuron Disease: A 4-Year Analysis of the Scottish Motor Neuron Disease Register.
Pearson I; Glasmacher SA; Newton J; Beswick E; Mehta AR; Davenport R; Chandran S; Pal S;
Neurodegener Dis; 2020; 20(4):147-152. PubMed ID: 33902047
[TBL] [Abstract][Full Text] [Related]
5. Health care professionals' views on psychological factors affecting nutritional behaviour in people with motor neuron disease: A thematic analysis.
Zarotti N; Coates E; McGeachan A; Williams I; Beever D; Hackney G; Norman P; Stavroulakis T; White D; White S; Halliday V; McDermott C;
Br J Health Psychol; 2019 Nov; 24(4):953-969. PubMed ID: 31449739
[TBL] [Abstract][Full Text] [Related]
6. A recent survey of augmentative and alternative communication use and service delivery experiences of people with amyotrophic lateral sclerosis in the United States.
Peters B; O'Brien K; Fried-Oken M
Disabil Rehabil Assist Technol; 2024 May; 19(4):1121-1134. PubMed ID: 36448513
[TBL] [Abstract][Full Text] [Related]
7. Changing epidemiology of motor neurone disease in Scotland.
Leighton DJ; Newton J; Stephenson LJ; Colville S; Davenport R; Gorrie G; Morrison I; Swingler R; Chandran S; Pal S;
J Neurol; 2019 Apr; 266(4):817-825. PubMed ID: 30805795
[TBL] [Abstract][Full Text] [Related]
8. Prospective observational cohort study of factors influencing trial participation in people with motor neuron disease (FIT-participation-MND): a protocol.
Beswick E; Glasmacher SA; Dakin R; Newton J; Carson A; Abrahams S; Chandran S; Pal S
BMJ Open; 2021 Mar; 11(3):e044996. PubMed ID: 33757953
[TBL] [Abstract][Full Text] [Related]
9. "Anything that makes life's journey better." Exploring the use of digital technology by people living with motor neurone disease.
Hobson EV; Fazal S; Shaw PJ; McDermott CJ
Amyotroph Lateral Scler Frontotemporal Degener; 2017 Aug; 18(5-6):378-387. PubMed ID: 28631958
[TBL] [Abstract][Full Text] [Related]
10. Variation in assistive technology use in Motor Neuron Disease according to clinical phenotypes and ALS Functional Rating Scale - Revised Score: A prospective observational study.
Connors K; Mahony L; Morgan P
NeuroRehabilitation; 2019; 44(2):303-313. PubMed ID: 31006691
[TBL] [Abstract][Full Text] [Related]
11. Relationship between neuropsychiatric disorders and cognitive and behavioural change in MND.
McHutchison CA; Leighton DJ; McIntosh A; Cleary E; Warner J; Porteous M; Chandran S; Pal S; Abrahams S
J Neurol Neurosurg Psychiatry; 2020 Mar; 91(3):245-253. PubMed ID: 31871139
[TBL] [Abstract][Full Text] [Related]
12. Clinical audit research and evaluation of motor neuron disease (CARE-MND): a national electronic platform for prospective, longitudinal monitoring of MND in Scotland.
Leighton D; Newton J; Colville S; Bethell A; Craig G; Cunningham L; Flett M; Fraser D; Hatrick J; Lennox H; Marshall L; McAleer D; McEleney A; Millar K; Silver A; Stephenson L; Stewart S; Storey D; Stott G; Thornton C; Webber C; Gordon H; Melchiorre G; Sherlock L; Beswick E; Buchanan D; Abrahams S; Bateman A; Preston J; Duncan C; Davenport R; Gorrie G; Morrison I; Swingler R; Chandran S; Pal S
Amyotroph Lateral Scler Frontotemporal Degener; 2019 May; 20(3-4):242-250. PubMed ID: 30889975
[No Abstract] [Full Text] [Related]
13. Supporting people with Motor Neuron Disease (MND) to make decisions about gastrostomy feeding tube placement: a survey of UK healthcare professionals' practice and beliefs.
White S; O'Cathain A; Halliday V; Bradburn M; McDermott CJ
Amyotroph Lateral Scler Frontotemporal Degener; 2024 May; 25(3-4):290-298. PubMed ID: 38337170
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with assistive technology prescription and acceptance in motor neurone disease.
Connolly A; Bailey S; Lamont R; Tu A
Disabil Rehabil Assist Technol; 2023 Oct; ():1-10. PubMed ID: 37897436
[TBL] [Abstract][Full Text] [Related]
15. Motor neurone disease: disability profile and service needs in an Australian cohort.
Ng L; Talman P; Khan F
Int J Rehabil Res; 2011 Jun; 34(2):151-9. PubMed ID: 21389864
[TBL] [Abstract][Full Text] [Related]
16. 'The shock of diagnosis': Qualitative accounts from people with Motor Neurone Disease reflecting the need for more person-centred care.
Aoun SM; O'Brien MR; Breen LJ; O'Connor M
J Neurol Sci; 2018 Apr; 387():80-84. PubMed ID: 29571877
[TBL] [Abstract][Full Text] [Related]
17. The Scottish Motor Neuron Disease Register: a prospective study of adult onset motor neuron disease in Scotland. Methodology, demography and clinical features of incident cases in 1989.
J Neurol Neurosurg Psychiatry; 1992 Jul; 55(7):536-41. PubMed ID: 1640227
[TBL] [Abstract][Full Text] [Related]
18. The impact of communication on healthcare involvement for people living with motor neurone disease and their carers: A longitudinal qualitative study.
Paynter C; Mathers S; Gregory H; Vogel AP; Cruice M
Int J Lang Commun Disord; 2022 Nov; 57(6):1318-1333. PubMed ID: 35860953
[TBL] [Abstract][Full Text] [Related]
19. Communication and cognitive impairments and health care decision making in MND: A narrative review.
Paynter C; Cruice M; Mathers S; Gregory H; Vogel AP
J Eval Clin Pract; 2019 Dec; 25(6):1182-1192. PubMed ID: 31282612
[TBL] [Abstract][Full Text] [Related]
20. Utility of Scottish morbidity and mortality data for epidemiological studies of motor neuron disease.
Chancellor AM; Swingler RJ; Fraser H; Clarke JA; Warlow CP
J Epidemiol Community Health; 1993 Apr; 47(2):116-20. PubMed ID: 8326268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
